We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RM icon
2626
Regional Management Corp
RM
$291M
$4.35K ﹤0.01%
128
+60
+88% +$1.88K
SBSW icon
2627
Sibanye-Stillwater
SBSW
$7.51B
$4.34K ﹤0.01%
1,316
-1,361
-51% -$5.73K
MEI icon
2628
Methode Electronics
MEI
$586M
$4.34K ﹤0.01%
368
-94
-20% -$1.02K
TPB icon
2629
Turning Point Brands
TPB
$1.78B
$4.33K ﹤0.01%
72
+45
+167% +$2.4K
LAZR
2630
DELISTED
Luminar Technologies
LAZR
$4.33K ﹤0.01%
+804
New +$8.49K
ORRF icon
2631
Orrstown Financial Services
ORRF
$828M
$4.32K ﹤0.01%
118
+19
+19% +$722
CLW icon
2632
Clearwater Paper
CLW
$375M
$4.32K ﹤0.01%
145
-437
-75% -$11.9K
DLX icon
2633
Deluxe
DLX
$1.14B
$4.32K ﹤0.01%
191
+44
+30% +$945
CRAI icon
2634
CRA International
CRAI
$1.08B
$4.31K ﹤0.01%
23
+12
+109% +$2.28K
WLDN icon
2635
Willdan Group
WLDN
$1.25B
$4.3K ﹤0.01%
113
+48
+74% +$2.06K
SCS
2636
DELISTED
Steelcase
SCS
$4.3K ﹤0.01%
364
+66
+22% +$849
HIPO icon
2637
Hippo Holdings
HIPO
$856M
$4.28K ﹤0.01%
160
+36
+29% +$885
XPRO icon
2638
Expro Ltd
XPRO
$1.98B
$4.28K ﹤0.01%
343
-1,723
-83% -$24K
NTLA icon
2639
Intellia Therapeutics
NTLA
$1.69B
$4.27K ﹤0.01%
366
+149
+69% +$2.33K
INFN
2640
DELISTED
Infinera Corporation Common Stock
INFN
$4.25K ﹤0.01%
647
+606
+1,478% +$4.04K
CHCT
2641
Community Healthcare Trust
CHCT
$434M
$4.25K ﹤0.01%
221
-79
-26% -$1.43K
BSAC icon
2642
Banco Santander Chile
BSAC
$16.6B
$4.24K ﹤0.01%
225
+138
+159% +$2.7K
AVDL
2643
DELISTED
Avadel Pharmaceuticals
AVDL
$4.24K ﹤0.01%
403
-880
-69% -$10.7K
PRKS icon
2644
United Parks & Resorts
PRKS
$2.07B
$4.21K ﹤0.01%
75
+3
+4% +$164
NBIS
2645
Nebius Group N.V.
NBIS
$47.3B
$4.21K ﹤0.01%
152
MYE icon
2646
Myers Industries
MYE
$1.24B
$4.2K ﹤0.01%
380
+50
+15% +$602
ACVA icon
2647
ACV Auctions
ACVA
$1.25B
$4.13K ﹤0.01%
191
-118
-38% -$2.39K
PHAT icon
2648
Phathom Pharmaceuticals
PHAT
$681M
$4.13K ﹤0.01%
508
+354
+230% +$4.38K
FOLD
2649
DELISTED
Amicus Therapeutics
FOLD
$4.1K ﹤0.01%
435
-503
-54% -$5.23K
MRAM icon
2650
Everspin Technologies
MRAM
$393M
$4.09K ﹤0.01%
640
+215
+51% +$1.33K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.